Literature DB >> 33616859

UCHL3 promotes aerobic glycolysis of pancreatic cancer through upregulating LDHA expression.

Y Fan1, D Hu1, D Li1, C Ma1, Y Tang1, Q Tao1, L Deng1, D Tang2.   

Abstract

BACKGROUND: Aerobic glycolysis has a pivotal role in the carcinogenic process. The current understanding of the functional role and mechanism of UCHL3-related aerobic glycolysis in pancreatic cancer is far from comprehensive, therefore requires an in-depth analysis on this aspect.
METHODS: In the present research, the expressions of ubiquitin carboxyl-terminal hydrolase L3 (UCHL3), lactate dehydrogenase A (LDHA) and Forkhead box protein M1 (FOXM1) were detected by qRT-PCR, Western blot and immunohistochemistry. The effects of UCHL3 knockdown or overexpression on pancreatic cancer cells were examined by determining cell viability and colony formation. Aerobic glycolysis was assessed according to glucose uptake, lactic acid production, and lactate dehydrogenase (LDH) activity. Dual-luciferase reporter assay was performed to detect LDHA promoter activity.
RESULTS: The results showed that UCHL3 expression was significantly increased in the pancreatic cancer tissues and cells, and that knocking down UCHL3 noticeably inhibited cell viability and aerobic glycolysis. Further investigations revealed that LDHA expression was promoted by UCHL3 and could be reduced by shFOXM1, and that low-expressed LDHA partly reversed the inhibition of aerobic glycolysis induced by overexpressed UCHL3.
CONCLUSIONS: To conclude, this study demonstrates that UCHL3 plays a carcinogenic role by promoting aerobic glycolysis in pancreatic cancer, suggesting that UCHL3 may be a potential diagnostic and therapeutic target for the treatment of cancer.

Entities:  

Keywords:  Glycolytic; Lactate dehydrogenase A; Pancreatic cancer; Ubiquitin carboxyl-terminal hydrolase L3

Year:  2021        PMID: 33616859     DOI: 10.1007/s12094-021-02565-1

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  27 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis.

Authors:  E Agarwal; C M Robb; L M Smith; M G Brattain; J Wang; J D Black; S Chowdhury
Journal:  Oncogene       Date:  2017-01-09       Impact factor: 9.867

3.  Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China.

Authors:  Jiang Long; Guo-pei Luo; Zhi-wen Xiao; Zu-qiang Liu; Meng Guo; Liang Liu; Chen Liu; Jin Xu; Yu-tang Gao; Ying Zheng; Chunxiao Wu; Quan-xing Ni; Min Li; Xianjun Yu
Journal:  Cancer Lett       Date:  2014-01-21       Impact factor: 8.679

Review 4.  What's new in the diagnosis of pancreatic cancer: a patent review (2011-present).

Authors:  Houria Boulaiz; María C Ramos; Carmen Griñán-Lisón; Maria E García-Rubiño; Francisca Vicente; Juan Antonio Marchal
Journal:  Expert Opin Ther Pat       Date:  2017-09-21       Impact factor: 6.674

5.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

6.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

7.  Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma.

Authors:  Xiu-Yan Huang; Zi-Li Huang; Bin Xu; Zi Chen; Thomas Joseph Re; Qi Zheng; Zhao-You Tang; Xin-Yu Huang
Journal:  J Exp Clin Cancer Res       Date:  2016-05-26

8.  Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.

Authors:  Ann E Zeleniak; Wei Huang; Mary K Brinkman; Melissa L Fishel; Reginald Hill
Journal:  Oncotarget       Date:  2017-03-07

9.  Combined Aberrant Expression of NDRG2 and LDHA Predicts Hepatocellular Carcinoma Prognosis and Mediates the Anti-tumor Effect of Gemcitabine.

Authors:  Yan Guo; Xi'an Li; Xiang Sun; Jiancai Wang; Xu Yang; Xin Zhou; Xinping Liu; Wenchao Liu; Jianlin Yuan; Libo Yao; Xia Li; Lan Shen
Journal:  Int J Biol Sci       Date:  2019-07-03       Impact factor: 6.580

10.  Molecular Mapping and Candidate Gene Analysis for GA3 Responsive Short Internode in Watermelon (Citrullus lanatus).

Authors:  Haileslassie Gebremeskel; Junling Dou; Bingbing Li; Shengjie Zhao; Umer Muhammad; Xuqiang Lu; Nan He; Wenge Liu
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

View more
  2 in total

Review 1.  The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism.

Authors:  Rongfu Tu; Junpeng Ma; Peng Zhang; Ye Kang; Xiaofan Xiong; Junsheng Zhu; Miao Li; Chengsheng Zhang
Journal:  Cancer Cell Int       Date:  2022-03-20       Impact factor: 5.722

Review 2.  Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis.

Authors:  Jiaqi Liu; Chi Tim Leung; Luyun Liang; Yuqin Wang; Jian Chen; Keng Po Lai; William Ka Fai Tse
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.